Intermittent androgen deprivation therapy in prostate cancer treatment: long-term multi-centre study results

Date Posted: 

A new study co-authored by Dr. Larry Goldenberg, urologic surgeon and researcher at the Vancouver Prostate Centre and head of the Department Urologic Sciences at UBC, has shown that prostate cancer patients who are given a “drug holiday” have the same survival rate as the continuous treatment group, and a far better quality of life.

Vancouver Coastal Health researchers and clinicians at the Vancouver Prostate Centre are pioneers in this field, having begun research and treatment of patients with intermittent therapy since the 1990s. The Centre has been an epicenter for this form of treatment and results from this large-scale study confirm earlier research. The study, which was published in New England Journal of Medicine (September 6, 2012), is expected to impact changes in prostate cancer protocols at other centres across Canada and worldwide.

Click here for more information and here for the reference at New England Journal of Medicine.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


2016 Step Up team

Step Up Challenge fundraiser: February 25, 2018

The annual Step Up Challenge, raising funds for Prostate Cancer Canada, takes place in Vancouver on Sunday February 25. Click here to sponsor our relay team as they climbs 379 floors. Click here to volunteer to help with the event.

It's a Snow Day poster

It's A Snow Day at Mt. Seymour: March 9

Mt. Seymour is hosting It's A Snow Day, a fundraiser for Prostate Cancer Foundation BC, on Friday March 9. The event will include slope time, a reception, and a silent auction. Click here for more details including how to register, donate and/or sponsor.




Work at the Vancouver Prostate Centre

Thursday, January 18, 2018

Discovery of a promising new medication to block "master key" of cancer growth

Dr. Chris Ong
Tuesday, February 20, 2018

Drs. Wyatt and Chi: ctDNA predicts resistance to AR-targeted therapy

VCHRI News article on study of ctDNA predicting resistance to AR-targeted therapy

Make A Difference

Help the Vancouver Prostate Centre fund research to find better treatments and a cure.